Medspas Approves Launch of Stock Repurchase Program and Votes No on the Utilization of a 504-D Offering

ATLANTA, GA, Jul 22 (MARKET WIRE) --
Medspas of America, Inc. (PINKSHEETS: MEDP), an emerging conglomerate in
the flourishing Health and Cosmeceutical industry, has approved the
launch of a repurchase shares program of its common stock via open market
purchases throughout fiscal 2008 as the Company deems appropriate.

Our intention is to continuously enhance shareholder value through the
buyback program by reducing the number of shares held by the public with
each opportunistic acquisition of our highly undervalued security. "We
find no better investment for our leftover retained profits than our own
company," stated CEO Paul Smith.

In a combination effort to protect and enhance shareholder value, the
Company has elected to not pursue any 504 Regulation D offerings to supply
its operating capital. "We feel the two initiatives reflect our
overwhelming confidence in Medspas' future. All the pieces are in place
with our advanced business model, demographics and trendline to make
Natural Renu a major revenue producer for the Company. We believe that
superior execution, strict financial discipline and prudent capital
deployment are the true keys to our overall success," stated CEO Paul
Smith.

About Natural Renu

The company has established a new division to penetrate the $5.4 billion
cosmeceutical industry under the brand name Natural Renu. The company's
new initiative is a line of cosmeceutical products focusing on the
anti-aging and skin healthcare markets. The company sales efforts are
focused primarily through two marketing channels. The first and primary
sales channel is Internet Retailing. The second target audience is to
exclusive Plastic Surgeons and Dermatology practices, Day spas, Resorts
and Medspas around the world.

SAFE HARBOR STATEMENT: Except for historical information contained herein,
the statements in this release are forward-looking statements that are
made pursuant to the safe harbour provisions of the Private Securities
Reform Act of 1995. Forward-looking statements involve known and unknown
risks and uncertainties, which may cause a company's actual results in
the future to differ materially from forecasted results. These risks and
uncertainties include, among other things, product price volatility,
product demand, market competition and risk inherent in the operations of
a company.

Investor Contact Information:

Paul Smith
Investor Relations
1-866-595-1081
Email Contact

Copyright 2008, Market Wire, All rights reserved.

-0-